These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 9234929)

  • 1. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer.
    Vassilopoulou-Sellin R; Theriault R; Klein MJ
    Gynecol Oncol; 1997 Apr; 65(1):89-93. PubMed ID: 9103397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and ovarian cancer.
    Folsom AR; Anderson JP; Ross JA
    Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
    Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL
    Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does HRT modify risk of gynecological cancers?
    Schneider HP; Birkhauser M
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical guide to prescribing estrogen replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy after treatment for localized breast carcinoma. Patient responses and opinions.
    Vassilopoulou-Sellin R; Klein MJ
    Cancer; 1996 Sep; 78(5):1043-8. PubMed ID: 8780542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
    J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.